Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum

by Maëlle Duffey, Cecilia P. Sanchez, Michael Lanzer
Published 2018-03-01

Knockout of the peroxiredoxin 5 homologue PFAOP does not affect the artemisinin susceptibility of Plasmodium falciparum

by Carine F. Djuika, Verena Staudacher, Cecilia P. Sanchez, Michael Lanzer, Marcel Deponte
Published 2017-06-01

Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite.

by Louise A Rodrigues, Gisela Henriques, Sofia T Borges, Paul Hunt, Cecília P Sanchez, Axel Martinelli, Pedro Cravo
Published 2010-07-01

Hemoglobin S and C affect protein export in Plasmodium falciparum-infected erythrocytes

by Nicole Kilian, Sirikamol Srismith, Martin Dittmer, Djeneba Ouermi, Cyrille Bisseye, Jacques Simpore, Marek Cyrklaff, Cecilia P. Sanchez, Michael Lanzer
Published 2015-02-01

A HECT ubiquitin-protein ligase as a novel candidate gene for altered quinine and quinidine responses in Plasmodium falciparum.

by Cecilia P Sanchez, Chia-Hao Liu, Sybille Mayer, Astutiati Nurhasanah, Marek Cyrklaff, Jianbing Mu, Michael T Ferdig, Wilfred D Stein, Michael Lanzer
Published 2014-05-01

Prokaryotic ancestry and gene fusion of a dual localized peroxiredoxin in malaria parasites

by Carine F. Djuika, Jaime Huerta-Cepas, Jude M. Przyborski, Sophia Deil, Cecilia P. Sanchez, Tobias Doerks, Peer Bork, Michael Lanzer, Marcel Deponte
Published 2015-01-01

Oxidative insult can induce malaria-protective trait of sickle and fetal erythrocytes

by Marek Cyrklaff, Sirikamol Srismith, Britta Nyboer, Kvetoslava Burda, Angelika Hoffmann, Felix Lasitschka, Sophie Adjalley, Cyrille Bisseye, Jacques Simpore, Ann-Kristin Mueller, Cecilia P. Sanchez, Friedrich Frischknecht, Michael Lanzer
Published 2016-11-01

SC83288 is a clinical development candidate for the treatment of severe malaria

by Stefano Pegoraro, Maëlle Duffey, Thomas D Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K Fehler, Leonardo Lucantoni, Vicky M Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J Vial, Stefan Strobl, Cecilia P Sanchez, Michael Lanzer
Published 2017-01-01

Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

by Stefano Pegoraro, Maëlle Duffey, Thomas D. Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K. Fehler, Leonardo Lucantoni, Vicky M. Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J. Vial, Stefan Strobl, Cecilia P. Sanchez, Michael Lanzer
Published 2017-04-01